XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Collaboration Agreements - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 31, 2018
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2009
USD ($)
Sep. 30, 2018
USD ($)
$ / shares
Sep. 30, 2017
USD ($)
$ / shares
Sep. 30, 2018
USD ($)
PerformanceObligation
$ / shares
Sep. 30, 2017
USD ($)
$ / shares
Dec. 31, 2012
USD ($)
Dec. 31, 2010
USD ($)
Jan. 01, 2018
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Collaboration revenue       $ 5,175,000 $ 12,557,000 $ 45,137,000 $ 38,094,000      
Net loss       $ (30,835,000) $ (12,308,000) $ (54,963,000) $ (30,993,000)      
Earnings per share, basic and diluted | $ / shares       $ (1.07) $ (0.50) $ (2.03) $ (1.34)      
AbbVie | License Agreement Terms                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Collaboration revenue           $ 0        
AbbVie | Collaborative Arrangement | Up-front Payment Arrangement                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Up-front collaboration payment received   $ 400,000,000                
Number of performance obligations | PerformanceObligation           3        
Collaboration revenue       $ 6,717,000   $ 19,931,000        
Deferred revenue       218,361,000   $ 218,361,000       $ 238,292,000
Deferred revenue, expected timing of recognition           2026-12        
KHK Agreement | License Agreement Terms                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Number of performance obligations | PerformanceObligation           3        
Deferred revenue       15,259,000   $ 15,259,000        
Cash received           30,000,000        
KHK Agreement | License Agreement Terms | Topic 606 | Difference between Revenue Guidance in Effect before and after Topic 606                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Net loss       $ (3,337,000)   $ (7,626,000)        
Earnings per share, basic and diluted | $ / shares       $ (0.12)   $ (0.28)        
KHK Agreement | Up-front Payment Arrangement | License Agreement Terms                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Upfront license fee received     $ 35,000,000              
KHK Agreement | Up-front Payment Arrangement | License Agreement Terms | Topic 606                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Upfront license fee received     35,000,000              
KHK Agreement | Regulatory Development Milestone | License Agreement Terms                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Collaboration revenue       $ (2,951,000)   $ 23,521,000        
Collaboration revenue, milestone payments received           45,000,000   $ 45,000,000 $ 45,000,000  
Collaboration revenue, potential milestone payments       52,000,000   52,000,000        
Regulatory milestone variable consideration achieved and is used in the transaction price           30,000,000        
Cumulative catch-up adjustment to collaboration revenue           21,881,000        
Remainder of transaction price to be recognized as performance obligation       8,119,000   8,119,000        
License fees and other expenses           3,600,000        
KHK Agreement | Regulatory Development Milestone | License Agreement Terms | Topic 606                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Collaboration revenue, milestone payments received $ 30,000,000   $ 15,000,000              
Collaboration agreements, additional remaining potential milestones not included in transaction price       52,000,000   52,000,000        
KHK Agreement | Commercial Milestones | License Agreement Terms                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Collaboration revenue, potential milestone payments       140,000,000   140,000,000        
KHK Agreement | Commercial Milestones | License Agreement Terms | Topic 606                    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                    
Collaboration agreements, additional remaining potential milestones not included in transaction price       $ 140,000,000   $ 140,000,000